Advertisement

Topics

Proposal to fund Erbitux for head and neck cancer in New Zealand

06:51 EST 15 Nov 2017 | thePharmaLetter

New Zealand’s Pharmaceutical Management Agency PHARMAC said today that it proposes to fund cetuximab…

Original Article: Proposal to fund Erbitux for head and neck cancer in New Zealand

NEXT ARTICLE

More From BioPortfolio on "Proposal to fund Erbitux for head and neck cancer in New Zealand"

Advertisement
Quick Search
Advertisement
Advertisement